Genetic Technologies (Australia) Market Value

GTG Stock   0.04  0.00  0.00%   
Genetic Technologies' market value is the price at which a share of Genetic Technologies trades on a public exchange. It measures the collective expectations of Genetic Technologies investors about its performance. Genetic Technologies is selling for under 0.039 as of the 30th of November 2024; that is No Change since the beginning of the trading day. The stock's last reported lowest price was 0.039.
With this module, you can estimate the performance of a buy and hold strategy of Genetic Technologies and determine expected loss or profit from investing in Genetic Technologies over a given investment horizon. Check out Genetic Technologies Correlation, Genetic Technologies Volatility and Genetic Technologies Alpha and Beta module to complement your research on Genetic Technologies.
For more information on how to buy Genetic Stock please use our How to Invest in Genetic Technologies guide.
Symbol

Please note, there is a significant difference between Genetic Technologies' value and its price as these two are different measures arrived at by different means. Investors typically determine if Genetic Technologies is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Genetic Technologies' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Genetic Technologies 'What if' Analysis

In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Genetic Technologies' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Genetic Technologies.
0.00
06/03/2024
No Change 0.00  0.0 
In 5 months and 30 days
11/30/2024
0.00
If you would invest  0.00  in Genetic Technologies on June 3, 2024 and sell it all today you would earn a total of 0.00 from holding Genetic Technologies or generate 0.0% return on investment in Genetic Technologies over 180 days. Genetic Technologies is related to or competes with Coronado Global. Genetic Technologies is entity of Australia More

Genetic Technologies Upside/Downside Indicators

Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Genetic Technologies' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Genetic Technologies upside and downside potential and time the market with a certain degree of confidence.

Genetic Technologies Market Risk Indicators

Today, many novice investors tend to focus exclusively on investment returns with little concern for Genetic Technologies' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Genetic Technologies' standard deviation. In reality, there are many statistical measures that can use Genetic Technologies historical prices to predict the future Genetic Technologies' volatility.
Hype
Prediction
LowEstimatedHigh
0.000.043.80
Details
Intrinsic
Valuation
LowRealHigh
0.000.033.79
Details
Naive
Forecast
LowNextHigh
0.00080.043.80
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
0.040.040.04
Details

Genetic Technologies Backtested Returns

Genetic Technologies holds Efficiency (Sharpe) Ratio of -0.0512, which attests that the entity had a -0.0512% return per unit of risk over the last 3 months. Genetic Technologies exposes twenty-five different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check out Genetic Technologies' Risk Adjusted Performance of 0.0255, downside deviation of 6.59, and Market Risk Adjusted Performance of 0.2731 to validate the risk estimate we provide. The company retains a Market Volatility (i.e., Beta) of 0.37, which attests to possible diversification benefits within a given portfolio. As returns on the market increase, Genetic Technologies' returns are expected to increase less than the market. However, during the bear market, the loss of holding Genetic Technologies is expected to be smaller as well. At this point, Genetic Technologies has a negative expected return of -0.19%. Please make sure to check out Genetic Technologies' information ratio, total risk alpha, treynor ratio, as well as the relationship between the jensen alpha and sortino ratio , to decide if Genetic Technologies performance from the past will be repeated at some point in the near future.

Auto-correlation

    
  0.56  

Modest predictability

Genetic Technologies has modest predictability. Overlapping area represents the amount of predictability between Genetic Technologies time series from 3rd of June 2024 to 1st of September 2024 and 1st of September 2024 to 30th of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Genetic Technologies price movement. The serial correlation of 0.56 indicates that roughly 56.0% of current Genetic Technologies price fluctuation can be explain by its past prices.
Correlation Coefficient0.56
Spearman Rank Test0.3
Residual Average0.0
Price Variance0.0

Genetic Technologies lagged returns against current returns

Autocorrelation, which is Genetic Technologies stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Genetic Technologies' stock expected returns. We can calculate the autocorrelation of Genetic Technologies returns to help us make a trade decision. For example, suppose you find that Genetic Technologies has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
   Current and Lagged Values   
       Timeline  

Genetic Technologies regressed lagged prices vs. current prices

Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Genetic Technologies stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Genetic Technologies stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Genetic Technologies stock over time.
   Current vs Lagged Prices   
       Timeline  

Genetic Technologies Lagged Returns

When evaluating Genetic Technologies' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Genetic Technologies stock have on its future price. Genetic Technologies autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Genetic Technologies autocorrelation shows the relationship between Genetic Technologies stock current value and its past values and can show if there is a momentum factor associated with investing in Genetic Technologies.
   Regressed Prices   
       Timeline  

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Genetic Stock Analysis

When running Genetic Technologies' price analysis, check to measure Genetic Technologies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Genetic Technologies is operating at the current time. Most of Genetic Technologies' value examination focuses on studying past and present price action to predict the probability of Genetic Technologies' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Genetic Technologies' price. Additionally, you may evaluate how the addition of Genetic Technologies to your portfolios can decrease your overall portfolio volatility.